Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dean G Tang

Showing results (101-110 of 133) with videos related to

Pageof 14
Sort By:
Medrxiv : the Preprint Server for Health Sciences|May 2, 2025
Phase Ib Study of Enzalutamide with Venetoclax in Patients with Metastatic Castration-Resistant Prostate CancerStuthi Perimbeti, Anmbreen Jamroze, Dharmesh Gopalakrishnan, et al.
Cancer Research|February 19, 2013
CD44-positive cancer stem cells expressing cellular prion protein contribute to metastatic capacity in colorectal cancerLei Du, Guanhua Rao, Hongyi Wang, et al.
The Journal of Clinical Investigation|June 2, 2022
A mitochondrial unfolded protein response inhibitor suppresses prostate cancer growth in mice via HSP60Rahul Kumar, Ajay K Chaudhary, Jordan Woytash, et al.
Cell Discovery|November 22, 2016
NANOG reprograms prostate cancer cells to castration resistance via dynamically repressing and engaging the AR/FOXA1 signaling axisCollene R Jeter, Bigang Liu, Yue Lu, et al.
BMC Genomics|July 13, 2019
Systematic evaluation of RNA-Seq preparation protocol performanceHsueh-Ping Chao, Yueping Chen, Yoko Takata, et al.
Plos One|March 7, 2014
Nanog1 in NTERA-2 and recombinant NanogP8 from somatic cancer cells adopt multiple protein conformations and migrate at multiple M.W speciesBigang Liu, Mark D Badeaux, Grace Choy, et al.
Cell Death and Differentiation|July 26, 2018
Mitochondrial ROS-derived PTEN oxidation activates PI3K pathway for mTOR-induced myogenic autophagyJin-Hwan Kim, Tae Gyu Choi, Seolhui Park, et al.
Cancer Chemotherapy and Pharmacology|November 28, 2025
Phase Ib study of enzalutamide with venetoclax in patients with metastatic castration-resistant prostate cancerStuthi Perimbeti, Anmbreen Jamroze, Dharmesh Gopalakrishnan, et al.
Cell Stem Cell|May 8, 2012
The PSA(-/lo) prostate cancer cell population harbors self-renewing long-term tumor-propagating cells that resist castrationJichao Qin, Xin Liu, Brian Laffin, et al.
The Journal of Biological Chemistry|February 13, 2002
Evidence that arachidonate 15-lipoxygenase 2 is a negative cell cycle regulator in normal prostate epithelial cellsShaohua Tang, Bobby Bhatia, Carlos J Maldonado, et al.
Pageof 14

Showing results (101-110 of 133) with videos related to

Sort By:
Pageof 14
Medrxiv : the Preprint Server for Health Sciences|May 2, 2025
Phase Ib Study of Enzalutamide with Venetoclax in Patients with Metastatic Castration-Resistant Prostate CancerStuthi Perimbeti, Anmbreen Jamroze, Dharmesh Gopalakrishnan, et al.
Cancer Research|February 19, 2013
CD44-positive cancer stem cells expressing cellular prion protein contribute to metastatic capacity in colorectal cancerLei Du, Guanhua Rao, Hongyi Wang, et al.
The Journal of Clinical Investigation|June 2, 2022
A mitochondrial unfolded protein response inhibitor suppresses prostate cancer growth in mice via HSP60Rahul Kumar, Ajay K Chaudhary, Jordan Woytash, et al.
Cell Discovery|November 22, 2016
NANOG reprograms prostate cancer cells to castration resistance via dynamically repressing and engaging the AR/FOXA1 signaling axisCollene R Jeter, Bigang Liu, Yue Lu, et al.
BMC Genomics|July 13, 2019
Systematic evaluation of RNA-Seq preparation protocol performanceHsueh-Ping Chao, Yueping Chen, Yoko Takata, et al.
Plos One|March 7, 2014
Nanog1 in NTERA-2 and recombinant NanogP8 from somatic cancer cells adopt multiple protein conformations and migrate at multiple M.W speciesBigang Liu, Mark D Badeaux, Grace Choy, et al.
Cell Death and Differentiation|July 26, 2018
Mitochondrial ROS-derived PTEN oxidation activates PI3K pathway for mTOR-induced myogenic autophagyJin-Hwan Kim, Tae Gyu Choi, Seolhui Park, et al.
Cancer Chemotherapy and Pharmacology|November 28, 2025
Phase Ib study of enzalutamide with venetoclax in patients with metastatic castration-resistant prostate cancerStuthi Perimbeti, Anmbreen Jamroze, Dharmesh Gopalakrishnan, et al.
Cell Stem Cell|May 8, 2012
The PSA(-/lo) prostate cancer cell population harbors self-renewing long-term tumor-propagating cells that resist castrationJichao Qin, Xin Liu, Brian Laffin, et al.
The Journal of Biological Chemistry|February 13, 2002
Evidence that arachidonate 15-lipoxygenase 2 is a negative cell cycle regulator in normal prostate epithelial cellsShaohua Tang, Bobby Bhatia, Carlos J Maldonado, et al.
Pageof 14